ARCHIVES

DCT Board reluctantly Okays Resources Contracts Recompetition, $6 of $10 Million Competitively

This article is from The Cancer Letter archive.

Vol. 03 No. 13 | April 1, 1977

Download PDF Visit The Full Archive

Related Articles

FDA Approves Taxotere And Gemzar; Sends Approvable Letter For Etopophos

May 24, 1996

Cancer Information Service facing $6 million cut, consolidation. Also Give NIH director greater authority, budget; review NCI’s special status, IOM says.

August 1, 2003

NCI Advisors Approve Expansion Of CCOPs, Minority-Based CCOPs; Approve Reissuance Of BMT Network RFA, RFPs For Preclinical Drug Studies

November 13, 2009

In Brief: Fishman La Jolla President Emeritus, Ruoslahti Succeeds Him; Ariz. Seeks Meyskins Replacement

January 13, 1989

Sen. Grassley Presses Amgen on “Bundling.”

April 11, 2008

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

November 30, 2012